Recall alert 🚨 Dynacare Baby powder recalled due to possible asbestos contamination

Parents, this is a recall alert we never want to hear, but safety comes first, especially when it involves the tiniest members of our families. Dynarex Corporation has expanded its recall of Dynacare Baby Powder (14 oz. and 4 oz. varieties) due to potential asbestos contamination, which was discovered through an FDA sampling program.

Asbestos, a known carcinogen, has serious health implications, making this recall especially important for families to be aware of and act on quickly.

Why the recall?

Asbestos is a naturally occurring mineral that’s sometimes found near talc, an ingredient commonly used in baby powders. While talc itself is safe, if not properly purified, it can contain asbestos. The FDA’s routine sampling found traces of asbestos in these Dynacare Baby Powder products, prompting the recall to prevent any risk to consumers. Dynarex has since halted all distribution of the affected products and is investigating how the contamination occurred.

The recall includes:

• 14 oz. Dynacare Baby Powder, item number 4875
• 4 oz. Dynacare Baby Powder, item number 4874

These products were distributed as early as January 18, 2024, across multiple states, including Alabama, California, New York, Texas, and many others. They were also available for purchase on Amazon, so if you’ve bought baby powder online, please check your order history.

If you have recently purchased Dynacare Baby Powder, please check for the following lot numbers located on the bottom of the bottle or case:

What should you do if you have the recalled baby powder?

1. Stop using the product. If you have a bottle of Dynacare Baby Powder, discontinue use immediately.
2. Return for a full refund. Return the product to the original place of purchase. Dynarex Corporation is facilitating refunds directly, so feel free to contact them at 888-396-2739 during business hours (8:30 AM – 5:00 PM EST) or via email at recall@dynarex.com.
3. Report concerns. The FDA encourages health professionals and consumers to report any reactions or health concerns to the MedWatch Adverse Event Reporting program.